DexCom’s Fair Value Estimate has recently been revised downward, moving modestly from $102.08 to $100.54 per share. This change reflects subtle shifts in analyst sentiment. While the company still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback